Vitiligo
Not recruitingStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
- Disease:Vitiligo
- Substances:Povorcitinib
Poland- Participants:18–64 years · 65+ years
- Substances:Povorcitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Poland229 clinical trials in Gdynia, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory viral infections, particularly evaluating new vaccines for elderly populations. Studies target both Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV).
Comprehensive research into treatments for various autoimmune disorders, including psoriatic arthritis and plaque psoriasis. Studies evaluate novel therapeutics like zasocitinib and tildrakizumab.
Innovative trials investigating treatments for heart failure prevention and cardiovascular disease. Studies examine combination therapies and novel compounds for improving cardiac outcomes.
Advanced research in breast cancer and prostate cancer treatments, focusing on metastatic disease and novel therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.